AAVantgarde News and Activities

Acquisition, funding and merger involving AAVantgarde.

• AAVantgarde has just announced a $141 Million fundraising (posted on November 4 2025).

View the org chart displaying its 18 main executives

Most searched biographies at AAVantgarde

• Natalia Misciattelli, Chief Executive Officer and Director
• Peter Kaiser, Non-Executive Director
• Michael Heffernan, Chairman of the Board

Create your alert
to follow the executive moves at AAVantgarde.

AAVantgarde has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by AAVantgarde

Social media about AAVantgarde

• AAVantgarde on Wikipedia, Google News & Yahoo Finance
• AAVantgarde on LinkedIn, X (Twitter) & YouTube